Oral vs Topical Minoxidil for Pattern Hair Loss: 2025 Meta-Analysis Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in Skin Health and Disease (Oxford), 2025
Oral vs Topical Minoxidil for Pattern Hair Loss: 2025 Meta-Analysis Research Summary
Study conclusion
This meta-analysis compared oral minoxidil (taken as a tablet) against topical minoxidil (applied to the scalp) in 4 randomised controlled trials involving 257 patients. There was no significant difference in hair density improvement between the two forms. Oral minoxidil was associated with higher rates of unwanted body hair growth (hypertrichosis).
Strength of evidence
Who it applies to
Who was studied
Adults with pattern hair loss (men and women). 257 participants across 4 RCTs. All oral minoxidil arms used 1mg once daily. Topical minoxidil arms used 5% in 3 trials and 2% in one trial.
Who was NOT studied
People using oral minoxidil at doses above 1mg. People with hair loss types other than androgenetic alopecia. Long-term users.
What to look for when shopping
Oral minoxidil is a prescription medication used off-label for hair loss. It is not FDA-approved for this use. The 1mg dose studied here is lower than doses commonly prescribed in clinical practice (2.5-5mg). Topical minoxidil 2% and 5% are FDA-approved.
What research cannot help you decide
Whether higher oral doses (2.5mg, 5mg) perform differently from topical minoxidil. Which form has better long-term tolerability for you. These questions require a prescribing doctor.
Key findings
- No significant difference in hair density improvement between oral 1mg and topical 5% minoxidil across 4 RCTs
- Oral minoxidil produced higher rates of unwanted body hair growth (hypertrichosis) than topical minoxidil
- Both forms produced significant improvements in hair density from baseline in the included trials
- Oral minoxidil dose in all included trials was 1mg — lower than doses commonly used in clinical practice today
- Oral minoxidil is not FDA-approved for hair loss
What this study does not show
- 1.Whether higher oral doses (2.5mg, 5mg) perform differently. All included trials used 1mg only.
- 2.Which form has better long-term tolerability. Trials ran 24-39 weeks.
- 3.Whether one form is better for women than men. Results were not consistently stratified by sex.
Limitations
- 1.Only 4 trials included — very thin evidence base for a direct comparison.
- 2.All oral minoxidil arms used 1mg — doses of 2.5mg and 5mg are more commonly prescribed clinically but were not studied here.
- 3.Total sample size of 257 is small for a definitive comparison.
- 4.Trial durations ranged from 24 to 39 weeks — long-term comparative data is absent.
Used in these articles
Links added as fact-checks and articles citing this study are published.